| The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia GC Issa, I Aldoss, J DiPersio, B Cuglievan, R Stone, M Arellano, ... Nature 615 (7954), 920-924, 2023 | 173 | 2023 |
| Multimodality treatment of desmoplastic small round cell tumor: chemotherapy and complete cytoreductive surgery improve patient survival V Subbiah, SE Lamhamedi-Cherradi, B Cuglievan, BA Menegaz, ... Clinical Cancer Research 24 (19), 4865-4873, 2018 | 78 | 2018 |
| Clinical activity of pazopanib in patients with advanced desmoplastic small round cell tumor BA Menegaz, B Cuglievan, J Benson, P Camacho, ... The oncologist 23 (3), 360-366, 2018 | 47 | 2018 |
| Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer D Ragoonanan, SJ Khazal, H Abdel-Azim, D McCall, B Cuglievan, ... Nature Reviews Clinical Oncology 18 (7), 435-453, 2021 | 46 | 2021 |
| Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements GC Issa, J Zarka, K Sasaki, W Qiao, D Pak, J Ning, NJ Short, F Haddad, ... Blood cancer journal 11 (9), 162, 2021 | 44 | 2021 |
| Venetoclax for children and adolescents with acute lymphoblastic leukemia and lymphoblastic lymphoma A Gibson, A Trabal, D McCall, S Khazal, L Toepfer, DH Bell, M Roth, ... Cancers 14 (1), 150, 2021 | 39 | 2021 |
| Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma ER Molina, LK Chim, MC Salazar, SM Mehta, BA Menegaz, ... Acta biomaterialia 100, 38-51, 2019 | 36 | 2019 |
| Preclinical efficacy of endoglin-targeting antibody–drug conjugates for the treatment of Ewing sarcoma P Puerto-Camacho, AT Amaral, SE Lamhamedi-Cherradi, BA Menegaz, ... Clinical Cancer Research 25 (7), 2228-2240, 2019 | 34 | 2019 |
| North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need N Pemmaraju, H Kantarjian, K Sweet, E Wang, J Senapati, NR Wilson, ... Blood 141 (6), 567-578, 2023 | 26 | 2023 |
| IGF-1R/mTOR targeted therapy for Ewing sarcoma: a meta-analysis of five IGF-1R-related trials matched to proteomic and radiologic predictive biomarkers HM Amin, AC Morani, NC Daw, SE Lamhamedi-Cherradi, V Subbiah, ... Cancers 12 (7), 1768, 2020 | 26 | 2020 |
| PET/CT versus bone marrow biopsy in the initial evaluation of bone marrow infiltration in various pediatric malignancies CP Zapata, B Cuglievan, CM Zapata, R Olavarrieta, S Raskin, K Desai, ... Pediatric blood & cancer 65 (2), e26814, 2018 | 26 | 2018 |
| Kikuchi-Fujimoto disease B Cuglievan, RN Miranda Blood, The Journal of the American Society of Hematology 129 (7), 917-917, 2017 | 26 | 2017 |
| Pediatric Hodgkin lymphoma, version 3.2021 JE Flerlage, SM Hiniker, S Armenian, EC Benya, AJ Bobbey, V Chang, ... Journal of the National Comprehensive Cancer Network 19 (6), 733-754, 2021 | 25 | 2021 |
| The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: updated results of a phase (Ph) 1 study GC Issa, I Aldoss, JF DiPersio, B Cuglievan, RM Stone, ML Arellano, ... Blood 140 (Supplement 1), 150-152, 2022 | 24 | 2022 |
| Impact of race, ethnicity, and socioeconomic status over time on the long-term survival of adolescent and young adult Hodgkin lymphoma survivors AM Berkman, CR Andersen, V Puthenpura, JA Livingston, S Ahmed, ... Cancer Epidemiology, Biomarkers & Prevention 30 (9), 1717-1725, 2021 | 23 | 2021 |
| Advances in the management of pediatric sarcomas FN Hernandez Tejada, A Zamudio, ML Marques-Piubelli, B Cuglievan, ... Current oncology reports 23, 1-9, 2021 | 22 | 2021 |
| 3D tissue-engineered tumor model for Ewing’s sarcoma that incorporates bone-like ECM and mineralization ER Molina, LK Chim, MC Salazar, GL Koons, BA Menegaz, ... ACS Biomaterials Science & Engineering 6 (1), 539-552, 2019 | 20 | 2019 |
| The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma SE Lamhamedi-Cherradi, M Maitituoheti, BA Menegaz, S Krishnan, ... Nature communications 13 (1), 3057, 2022 | 19 | 2022 |
| Early results of the phase I/II study investigating the all-oral combination of the menin inhibitor revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax … GC Issa, B Cuglievan, CD DiNardo, NJ Short, D McCall, A Gibson, ... Blood 142, 58, 2023 | 18 | 2023 |
| Long-term outcomes among adolescent and young adult survivors of acute leukemia: a surveillance, epidemiology, and end results analysis AM Berkman, CR Andersen, B Cuglievan, DC McCall, PJ Lupo, ... Cancer Epidemiology, Biomarkers & Prevention 31 (6), 1176-1184, 2022 | 17 | 2022 |
